China vs Pakistan: New or unknown treatment history cases: Pulmonary, bacteriologically
China
326,625
in 2023
Pakistan
184,918
in 2023
China rank
3rd
Pakistan rank
6th
New or unknown treatment history cases: Pulmonary, bacteriologically over time
- China
- Pakistan
How they compare
China currently reports 326,625 against 184,918 in Pakistan, a difference of 141,707.
That makes China's figure about 1.8 times Pakistan's.
Across all 11 years both countries report, China has been ahead every year.
China ranks 3rd and Pakistan ranks 6th of 197 countries.
China has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | China | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 241,700 | 123,933 | 117,767 | China |
| 2020s | 297,397 | 148,541 | 148,856 | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new or unknown treatment history cases: pulmonary, bacteriologically, China or Pakistan?
- China, at 326,625 against 184,918 in Pakistan as of 2023.
- What is the difference in new or unknown treatment history cases: pulmonary, bacteriologically between China and Pakistan?
- 141,707, with China ahead.
- How many years of comparable data are there for China and Pakistan?
- 11 years are reported by both, from 2013 to 2023.
- How do China and Pakistan rank globally for new or unknown treatment history cases: pulmonary, bacteriologically?
- China ranks 3rd and Pakistan ranks 6th of 197 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New or unknown treatment history cases: Pulmonary, bacteriologically confirmed. Statizoid refreshes it automatically from the source and publishes the full history for both places.